Complementation of Lymphotoxin α Knockout Mice with Tumor Necrosis Factor–expressing Transgenes Rectifies Defective Splenic Structure and Function by Alexopoulou, Lena et al.
 
745
 
J. Exp. Med. 
 
Ó
 
 The Rockefeller University Press • 0022-1007/98/08/745/10 $2.00
Volume 188, Number 4, August 17, 1998 745–754
http://www.jem.org
 
Complementation of Lymphotoxin 
 
a
 
 Knockout Mice
with Tumor Necrosis Factor–expressing Transgenes
Rectiﬁes Defective Splenic Structure and Function
 
By Lena Alexopoulou, Manolis Pasparakis, and George Kollias
 
From the Department of Molecular Genetics, Hellenic Pasteur Institute, 115 21 Athens, Greece
 
Summary
 
Lymphotoxin (LT)
 
a
 
 knockout mice, as well as double LT
 
a
 
/tumor necrosis factor (TNF)
knockout mice, show a severe splenic disorganization with nonsegregating T/B cell zones and
complete absence of primary B cell follicles, follicular dendritic cell (FDC) networks, and ger-
minal centers. In contrast, as shown previously and confirmed in this study, LT
 
b
 
-deficient
mice show much more conserved T/B cell areas and a reduced but preserved capacity to form
germinal centers and FDC networks. We show here that similar to the splenic phenotype of
LT
 
b
 
-deficient mice, complementation of LT
 
a
 
 knockout mice with TNF-expressing trans-
genes leads to a p55 TNF receptor–dependent restoration of B/T cell zone segregation and a
partial preservation of primary B cell follicles, FDC networks, and germinal centers. Notably,
upon lipopolysaccharide challenge, LT
 
a
 
 knockout mice fail to produce physiological levels of
TNF both in peritoneal macrophage supernatants and in their serum, indicating a coinciding
deficiency in TNF expression. These findings suggest that defective TNF expression contrib-
utes to the complex phenotype of the LT
 
a
 
 knockout mice, and uncover a predominant role
for TNF and its p55 TNF receptor in supporting, even in the absence of LT
 
a
 
, the develop-
ment and maintenance of splenic B cell follicles, FDC networks, and germinal centers.
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T
 
umor necrosis factor (TNF), lymphotoxin 
 
a
 
 (LT
 
a
 
),
 
1
 
and LT
 
b
 
 are structurally homologous cytokines, and
their genes are closely clustered within the MHC (1, 2). TNF
is expressed mainly by macrophages and T cells as either a
transmembrane protein or a soluble homotrimeric molecule
(3). LT
 
a
 
 exists as a soluble homotrimer (LT
 
a
 
3
 
) but also on
the membrane of activated lymphocytes in heterotrimeric
complexes with LT
 
b
 
 (1). TNF and LT
 
a
 
3
 
 use the same cell
surface receptors, the p55 and p75 TNFRs, which are ex-
pressed on a wide variety of cells (4), whereas the predomi-
nant surface LT
 
a
 
1
 
b
 
2
 
 heterotrimer binds to the LT
 
b
 
R,
which is expressed on cells of nonhematopoietic origin (5).
Recent studies in gene-targeted mice have revealed es-
sential roles for TNF, LT
 
a
 
, and LT
 
b
 
 in secondary lym-
phoid organ structure and function. TNF was found to be
essential for the formation of primary B cell follicles, follic-
ular dendritic cell (FDC) networks, and germinal centers in
all secondary lymphoid organs (6, 7). LT
 
a
 
 knockout mice
lack lymph nodes and Peyer’s patches and show a severe
disorganization of splenic architecture where B/T cell areas
do not segregate, marginal zones are absent, and FDC net-
works and germinal centers do not form (8, 9). Interest-
ingly, mice deficient in both the LT
 
a
 
 and TNF genes show
a phenotype identical to the LT
 
a
 
 knockout phenotype
(10). Remarkably, however, these phenotypes were not
fully reproduced in LT
 
b
 
 knockout mice, in which mesen-
teric and cervical lymph nodes do develop, splenic white
pulp lymphocytes segregate into B/T cell zones (11, 12), and
some capacity to form FDC networks and germinal centers
is preserved (12). These discrepancies led to the hypothesis
that LT
 
a
 
 should have additional functions independent of
LT
 
b
 
 in the organogenesis of mesenteric and cervical lymph
nodes and in the formation of distinct B/T cell areas, FDC
networks, and germinal centers in the spleen.
The apparently similar phenotypes of LT
 
a
 
 and double
TNF/LT
 
a
 
 (10) knockout mice and the differences these
mice show when compared with LT
 
b
 
 knockout mice (11–
13) have led us to search for functional redundancies in the
TNF/LT system by complementing LT
 
a
 
 knockout mice
with TNF-expressing transgenes. Surprisingly, although
the lack of mesenteric and peripheral lymph nodes and
 
1
 
Abbreviations used in this paper:
 
 FDC, follicular dendritic cell; LT, lym-
photoxin; PNA, peanut agglutinin; TD, T cell–dependent; Tg, trans-
genic; UTR, untranslated region.
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Peyer’s patches could not be rescued by transgenic expres-
sion of TNF, TNF-complemented LT
 
a
 
 knockout mice
displayed intact T/B cell segregation and retained a subop-
timal capacity to develop primary B cell follicles that con-
tained FDC networks and could support the formation
of germinal centers. TNF-mediated restoration of LT
 
a
 
knockout splenic architecture was dependent on the pres-
ence of the p55TNFR. These observations suggested that
altered TNF expression may contribute to the complex
splenic phenotype of the LT
 
a
 
 knockout mice. Indeed, de-
fective TNF production in the LT
 
a
 
 knockout mice could
be documented by measuring TNF accumulation in LPS-
stimulated sera and in the supernatants of macrophages
from LT
 
a
 
 knockout mice. Our studies support a model
where LTs function to provide the optimal reticular/stro-
mal splenic architecture for the efficient formation of B cell
follicles and FDC networks, phenomena primarily depen-
dent on TNF/p55TNFR interactions.
 
Materials and Methods
 
Mice.
 
LT
 
a
 
 knockout mice (8) were obtained from The Jack-
son Laboratory (Bar Harbor, ME); LT
 
b
 
 knockout (12) mice were
provided by Dr. K. Pfeffer (Technical University of Munich,
Munich, Germany); and p55TNFR-deficient (14) mice were
provided by Dr. H. Bluethmann (Hoffman-LaRoche Inc., Basel,
Switzerland). Transgenic (Tg)1278 mice carrying 
 
z
 
3 copies of a
genomic 3.6-kb DNA fragment containing the entire wild-type
human TNF gene together with 0.6 and 0.8 kb of 5
 
9
 
 and 3
 
9
 
flanking sequences, respectively (15), and TgA86 mice carrying
 
z
 
50 copies of a 3.2-kb hybrid TNF/globin transgene construct
containing the promoter of the murine TNF gene, the coding se-
quence of the murine TNF
 
D
 
1-12
 
 gene (16), and the 3
 
9
 
-untranslated
region (UTR) and polyadenylation site of the human 
 
b
 
-globin
gene (16) have been previously generated in our laboratory.
Tg1278 and TgA86 mice were always heterozygous for the TNF
transgenes. All mice used in this study were maintained under
specific pathogen–free barriers in the animal facilities of the
Hellenic Pasteur Institute and analyzed between 6 and 12 wk of age.
 
Immunocytochemical Analysis of Splenic Structure.
 
Spleens were har-
vested, embedded in O.C.T. compound (BDH Laboratory Sup-
plies, Dorset, UK), and frozen in liquid nitrogen. Cryostat
sections were cut at 7 
 
m
 
m, thaw-mounted on gelatinized slides,
air dried, and stored desiccated at 
 
2
 
20
 
8
 
C. Immediately before
use, sections were fixed for 10 min in acetone containing 0.03%
H
 
2
 
O
 
2
 
 to block endogenous peroxidase activity, followed by rehy-
dration in PBS. All antibodies were diluted in PBS/0.1% BSA.
For double immunostaining with anti-B220 and anti-CD3, sec-
tions were incubated with rat anti-CD3 clone KT3 (reference 17;
provided by Dr. S. Gobbold, Sir William Dunn School of Pathol-
ogy, Oxford, UK) followed by peroxidase-conjugated goat anti–
rat IgG (Southern Biotechnology Associates, Inc., Birmingham,
AL). After blocking with 20% normal rat serum in PBS, sections
were incubated with biotin-conjugated rat anti-B220 (PharMin-
gen, San Diego, CA), followed by avidin–alkaline phosphatase
(ABC-AP kit; Vector Laboratories, Inc., Burlingame, CA). Dou-
ble staining for IgM and IgD was performed as described else-
where (6). For the analysis of FDC networks and germinal cen-
ters, mice were immunized with an intraperitoneal injection of
10
 
8
 
 SRBC in PBS, and spleens were removed 10 d later. For
double immunostaining of B cells and FDC networks or germinal
centers, sections were incubated with rat anti-B220 (PharMin-
gen), followed by peroxidase-conjugated goat anti–rat IgG. After
blocking with 20% normal rat serum in PBS, sections were incu-
bated with biotinylated anti–mouse complement receptor (CR)1
antibody (8C12; PharMingen [18]) or biotinylated peanut agglu-
tinin (PNA; Sigma Chemical Co., St. Louis, MO), followed by
avidin–alkaline phosphatase. In all of the above stainings, bound
peroxidase activity was developed with diaminobenzidine (DAB;
Sigma Chemical Co.), and alkaline phosphatase activity was visu-
alized with naphthol AS-MX phosphate (Sigma Chemical Co.)
and fast blue BB salt (Sigma Chemical Co.). For double staining
with ER-TR9 and antisialoadhesin, sections were incubated with
ER-TR9 (reference 19; provided by Dr. P. Leenen, Erasmus
University, Rotterdam, The Netherlands) followed by alkaline
phosphatase–conjugated goat anti–rat IgM/IgG (Southern Bio-
technology Associates, Inc.). After blocking with 20% normal rat
serum in PBS, sections were incubated with biotinylated rat anti-
sialoadhesin (provided by Dr. P.R. Crocker, University of
Oxford, Oxford, UK [20]) followed by peroxidase-conjugated
streptavidin. Bound peroxidase activity was detected by staining
with amino-ethylcarbazol (Sigma Chemical Co.), and alkaline
phosphatase activity was visualized with naphthol AS-MX phos-
phate and fast blue BB salt. All incubations were carried out un-
der humidified conditions, and slides were washed in PBS be-
tween steps.
 
Immunization Protocol.
 
Indicated groups of mice were immu-
nized intraperitoneally with 10
 
8
 
 SRBC in PBS on days 0 and 21.
Mice were bled on day 28 for measurement of anti-SRBC serum
antibodies.
 
ELISA for SRBC-specific Serum Antibodies.
 
Sera from immu-
nized mice were assayed using SRBC-specific ELISA for IgG1
antibodies as described previously (6). In brief, 96-well Immuno-
Maxisorp plates (Nunc, Roskilde, Denmark) were coated with a
solubilized extract from SRBC (100 
 
m
 
l at 5 
 
m
 
g/ml [21]) sus-
pended in carbonate buffer, pH 9.6. Plates were washed with
0.05% Tween 20 in PBS and blocked with 1% BSA in PBS. Se-
rum samples diluted in PBS containing 0.05% Tween 20, 1%
BSA, and 1 M NaCl were incubated overnight at 4
 
8
 
C. Horserad-
ish peroxidase–conjugated goat anti–mouse IgG1 (Southern Bio-
technology Associates, Inc.) was diluted 1:5,000 in PBS contain-
ing 1% BSA, and 100 
 
m
 
l/well was added and incubated for 1 h at
room temperature. ELISAs were developed with 0.4 mg/ml
 
o
 
-phenyldiamine dihydrochloride (Sigma Chemical Co.) in 0.05 M
phosphate-citrate buffer, pH 5.0, containing 0.03% H
 
2
 
O
 
2
 
,
stopped with 2 M H
 
2
 
SO
 
4
 
, and OD
 
490
 
 from duplicate wells was
measured using a microplate reader (MRX; Dynatech Laborato-
ries, Inc., Chantilly, VA).
 
Measurement of TNF Production after LPS Stimulation.
 
Levels of
TNF in macrophage supernatants and sera were determined as
described previously (16). In brief, thioglycollate-elicited perito-
neal macrophages were seeded at 5 
 
3
 
 10
 
5
 
 cells/ml and incubated
in the presence of 1 
 
m
 
g/ml LPS (
 
Salmonella enteritidis
 
, L6011;
Sigma Chemical Co.) at 37
 
8
 
C, 5% CO
 
2
 
 for 24 h. Mice were in-
jected intraperitoneally with 100 
 
m
 
g LPS in 0.5 ml PBS, and 90
min later blood samples were collected by cardiac puncture. The
ELISA assay for murine TNF was provided by Dr. Wim Buur-
man (University of Limburg, Maastricht, The Netherlands) and
performed as described previously (22).
 
Results
 
TNF-complemented LT
 
a
 
 Knockout Mice.
 
LT
 
a
 
 knockout
mice (8, 9) as well as double LT
 
a
 
/TNF knockout mice (10) 
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show a more severe disorganization of their splenic archi-
tecture compared with TNF (6) or LT
 
b
 
 knockout mice
(11, 12). To determine whether the additional lymphoid
abnormalities seen in the LT
 
a
 
 knockout mice may be res-
cued by TNF-specific signals, we complemented LT
 
a
 
knockout mice with TNF-expressing transgenes (TgTNF/
LT
 
a
 
2
 
/
 
2
 
). Two previously characterized TNF transgenic
lines were used: Tg1278 mice expressing a human wild-
type TNF transgene (15) and TgA86 mice expressing a mu-
tant transmembrane form of murine TNF from a TNF
 
D
 
1-12
 
/
globin hybrid gene construct (reference 16, and see Materi-
als and Methods). Tg1278 mice are free of pathology and
express a low level of wild-type human TNF mRNA in
several tissues, including thioglycollate-elicited peritoneal
macrophages, thymus, lung, spleen, kidney, brain, skin, and
joints. Similar to endogenous murine TNF, low-level
mRNA expression of the wild-type human TNF transgene
does not result in a detectable level of TNF protein secre-
tion in either sera or supernatants from thioglycollate-
elicited peritoneal macrophages as assessed by ELISA or
cytotoxicity assays (not shown). However, after LPS stimu-
lation of ex vivo peritoneal macrophages, correct upregula-
tion of transgene mRNA (15) and of protein production
(not shown) could be demonstrated. On the other hand,
TgA86 mice express a constitutively high level of the
TNF
 
D
 
1-12
 
/globin mRNA in several tissues, including thio-
glycollate-elicited peritoneal macrophages, thymus, lung,
spleen, mesenteric lymph nodes, kidney, heart, brain, skin,
and joints (16). Constitutive overproduction of a bioactive
transmembrane TNF protein is suggested by the develop-
ment of chronic inflammatory arthritis in these mice (16),
indicating aberrant regulation probably resulting from the
absence of the putatively suppressive TNF 3
 
9
 
-UTR from
the mRNA of this specific transgene.
Macroscopic examination of TNF-complemented LT
 
a
 
knockout mice (
 
n
 
 .
 
7 per transgenic line) showed that they
lack mesenteric and peripheral lymph nodes and Peyer’s
patches, confirming a TNF-independent role for LTs in
the organogenesis of these lymphoid tissues. However, in
both TgTNF/LT
 
a
 
2
 
/
 
2
 
 mouse lines, a substantial preserva-
tion of splenic structure could be observed (see below), in-
dicating a composite nature of the LT
 
a
 
 null mutation.
 
Rescued Splenic T/B Cell Segregation in TNF-complemented
LT
 
a
 
 Knockout Mice Is p55TNFR Dependent.
 
Double im-
munostaining with anti-B220 and anti-CD3 antibodies in
spleen sections of Tg1278/LT
 
a
 
2
 
/
 
2
 
 and TgA86/LT
 
a
 
2
 
/
 
2
 
mice revealed a conserved segregation of B and T cell
zones, with T cells clustered around the central arterioles
and B cells located peripheral to the T cell zone (Fig. 1).
This structural feature is directly comparable to the appear-
ance of B/T cell areas in the spleens of LT
 
b
 
2
 
/
 
2
 
 mice (Fig.
1), but is lacking completely in the spleens of LT
 
a
 
 knock-
out mice (reference 8, and Fig. 1). These results show that
even in the absence of LTa, TNF is sufficient to maintain
correct segregation of B/T cell areas in the spleen.
To assess whether the observed involvement of TNF in
rescuing B/T cell segregation in LTa knockout mice is
p55TNFR dependent, double TgA86/LTa2/2 mice were
bred into a p55TNFR knockout background (14). Splenic
architecture in triple TgA86/LTa2/2/p55TNFR2/2 mice
remained indistinguishable from control LTa2/2 mice
(Fig. 1) and LTa2/2/p55TNFR2/2 mice (not shown),
demonstrating that in the absence of the p55TNFR, trans-
genic TNF expression could not rescue the splenic pheno-
type in LTa knockout mice. Therefore, restoration of
splenic structure in LTa knockout mice by TNF is medi-
ated via the p55TNFR.
Rectified B Cell Follicles and FDC Networks but Absent Mar-
ginal Zones in Spleens from TgTNF/LTa2/2 Mice. To deter-
mine whether transgenic TNF expression could reconsti-
tute deficient follicular organization in LTa knockout
mice, we analyzed splenic sections from TgTNF/LTa2/2
mice using double immunostaining with anti-IgM and
anti-IgD antibodies. By this staining, B cell follicles con-
taining IgM1/IgD1 B cells can be clearly discriminated
from the IgMhigh/IgDlow marginal zone B cell population in
splenic sections from wild-type mice (Fig. 1). Consistent
with previous studies (23), double IgM/IgD staining revealed
the absence of follicular organization in spleens from LTa
knockout mice (Fig. 1). However, similar analyses in spleens
from Tg1278/LTa2/2, TgA86/LTa2/2, and LTb2/2 mice
(Fig. 1) revealed the presence of organized primary B cell
follicles although at reduced size and numbers compared
with wild-type controls. Double immunostaining with
anti-B220 as a marker for B cells, and an antibody to CR1
(mAb 8C12) as a marker for FDCs (18), showed that the
follicular structures observed in TgTNF/LTa2/2 and LTb2/2
mice contain networks of CR11 FDCs (Fig. 2). These
FDC networks were greatly diminished in number and
size; however, similar to wild-type FDCs, they showed a
typical network organization and follicular localization.
Thus, even in the absence of LTa, TNF has the capacity to
support, albeit suboptimally, the development and main-
tenance of organized B cell follicles and FDC networks.
To examine the structure of the splenic marginal zone in
TgTNF/LTa2/2 mice, we performed immunocytochemi-
cal analysis of splenic sections using markers specific for the
specialized macrophage populations of the marginal zone.
Double immunostaining with ER-TR9, an mAb recogniz-
ing marginal zone macrophages (19), and the 1C2 mAb
against mouse sialoadhesin (20), which stains specifically the
metallophilic macrophages in the spleen (24), revealed the
characteristic concentric organization of these macrophage
subsets peripheral to the white pulp in spleen sections from
wild-type mice (Fig. 2). However, similar to spleen sections
from LTa knockout mice (Fig. 2), double ER-TR9/antisi-
aloadhesin staining of sections from TgTNF/LTa2/2 and
LTb2/2 spleens showed the absence of these macrophage
populations of the marginal zone (Fig. 2). Absence of metal-
lophilic macrophages was also shown using the MOMA-1
mAb (data not shown; provided by G. Kraal, Vrije Univer-
siteit, Amsterdam, The Netherlands), and staining using the
R3-3C12C7 anti–mucosal addressin cell adhesion mole-
cule 1 mAb (provided by B. Holzmann, Technical Univer-
sity of Munich, Munich, Germany) demonstrated the com-
plete absence of marginal zone mucosal addressin cell748 Role of TNF/LT in Splenic Architecture749 Alexopoulou et al.
adhesion molecule 1 expression from the spleens of LTa2/2,
Tg1278/LTa2/2, TgA86/LTa2/2, and LTb2/2 mice (not
shown). Deficient marginal zone formation in these mice
was also confirmed by the absence of the characteristic
Ig-Mhigh/IgDlow marginal zone B cell population as assessed
by double IgM/IgD staining (Fig. 1). Taken together, these
data confirm the requirement for LT function in the devel-
opment of the splenic marginal zone.
Germinal Center Formation and IgG Antibody Responses in
TgTNF/LTa2/2 Mice. To investigate whether the recti-
fied follicular organization in TgTNF/LTa2/2 mice could
support development of germinal centers, we analyzed ger-
minal center formation in the spleens of wild-type, LTa2/2,
LTb2/2, and TgTNF/LTa2/2 mice 10 d after immuniza-
tion with the T cell–dependent (TD) antigen SRBC. Dou-
ble immunocytochemical analysis using anti-B220 antibod-
ies as a B cell marker and PNA as a marker for germinal
center B cells demonstrated the presence of typical germinal
centers forming within B cell follicles in wild-type mice
(Fig. 2). Consistent with previous studies (9), control LTa2/2
mice did not form typical germinal centers, although rare
aggregates of PNA1 cells could be detected around central
arterioles (reference 12, and Fig. 2). Similar analyses of
spleen sections from immunized Tg1278/LTa2/2, TgA86/
LTa2/2, and LTb2/2 mice revealed the presence of PNA1
germinal centers forming within B cell follicles (Fig. 2).
Although the number and size of these germinal centers
are reduced compared with wild-type mice, their forma-
tion within B cell follicles, their typical appearance as
B2201IgD2 areas surrounded by IgD1 follicular mantle B
cells (not shown), and the finding that they contain FDC
networks distinguish them from the PNA1 patches often
observed to form around central arterioles in LTa (12) and
TNF knockout mice (6).
To investigate the ability of the TNF-complemented
LTa knockout mice to respond to a TD immunization, we
tested the secondary antibody responses of TgTNF/LTa2/2
mice to the TD antigen SRBC. Wild-type, Tg1278/
LTa2/2, and LTa2/2 mice were immunized intraperito-
neally with SRBC on days 0 and 21, and anti-SRBC IgG1
antibody responses were measured on day 28 using an anti-
gen-specific ELISA. Tg1278/LTa2/2 mice showed in-
creased levels of IgG1 anti-SRBC antibodies compared
with LTa2/2 mice, although they could not reach the lev-
els produced by wild-type mice (Fig. 3). Similar results
were observed using TgA86/LTa2/2 mice (data not shown).
Thus, the observed germinal centers in the TNF-comple-
mented LTa2/2 mice appear functional and contribute
positively, albeit suboptimally, to the development of a TD
humoral immune response.
A Reduced Level of TNF Production in LTa Knockout
Mice. Given the surprising result of partial reconstitution
of the splenic phenotype of the LTa knockout mice with
TNF-expressing transgenes, and the striking similarities in
the splenic architecture of TgTNF/LTa2/2 and LTb2/2
mice, it would seem likely that the splenic phenotype of
the LTa knockout mice could actually result from a coex-
istent deficiency in TNF production in these mice. To ad-
dress this question, we measured levels of TNF protein
production in LPS-stimulated LTa knockout mouse sera
or ex vivo peritoneal macrophage supernatants. Compared
with background-matched wild-type control mice, LTa
knockout mice show severely reduced accumulation of
TNF protein in both sera and macrophage exudates (Fig.
4), indicating that in addition to the LTa null mutation,
this strain of mice may show further complications due to
inherent defects in the neighboring TNF gene expression.
Further analyses should address the underlying mechanism
producing the additional defect on TNF expression and as-
sess the impact of this phenomenon in the interpretation
of different phenotypes occurring in the LTa knockout
mouse strain.
Discussion
Targeted disruption of genes encoding ligands and re-
ceptors in the TNF/LT family have clearly established the
important roles these molecules play in regulating the de-
velopment and function of secondary lymphoid tissues (13,
25, 26). From these studies, a role has been proposed for
LTab heterotrimers, presumably signaling through the
LTbR, in the organogenesis of lymph nodes and Peyer’s
patches and in the regulation of splenic structural organiza-
tion. However, apparent differences between the lymphoid
phenotypes of LTa and LTb knockout mice suggested that
LTa should have additional biological activities indepen-
dent of LTb (11–13). For example, defects in splenic T/B
cell organization and complete absence of FDC networks
and typical germinal centers in LTa or double LTa/TNF
knockout mice (8–10) could not be fully reproduced in
LTb-deficient mice (12), which show more conserved B/T
cell organization and retain some capacity to form FDC
networks and germinal centers (Figs. 1 and 2). Using com-
plementation analysis, we show in this study that many of
the phenotypic complications of LTa knockout mice in
the spleen may be compensated by the reintroduction of
functional TNF transgenes. Complementation of LTa
knockout mice with TNF-encoding transgenes leads to a
p55TNFR-dependent restoration of B/T cell zone segre-
gation and to the partial preservation of B cell follicles,
Figure 1. Rescued T/B cell segregation and B cell follicle formation in TgTNF/LTa2/2 mice is p55TNFR dependent. Immunocytochemical analysis
was performed on cryostat sections of spleens from wild-type (WT), LTa2/2, LTb2/2, 1278/LTa2/2, A86/LTa2/2, and A86/LTa2/2/p55TNFR2/2
mice. Sections were stained with anti-B220 (blue) for B cells, anti-CD3 (brown) for T cells, anti-IgM (brown) for IgM1 B cells, and anti-IgD (blue) for
IgD1 B cells. Original magnifications: 340 for B220/CD3 staining, and 3100 for IgM/IgD staining.750 Role of TNF/LT in Splenic Architecture751 Alexopoulou et al.
FDC networks, and germinal centers. Interestingly, the
TNF-complemented LTa-deficient phenotype is strikingly
similar to the splenic phenotype of LTb-deficient mice, as
demonstrated in this study (Figs. 1 and 2). These observa-
tions suggest that defective TNF expression may contribute
to the complex phenotype of the LTa knockout mice. Al-
ternatively, it may be suggested that complementation of
the LTa knockout phenotype by TNF is due to a substitu-
tion for LT function rather than restoration of defective
TNF expression, for example by transgenic overexpression
of TNF. However, this seems unlikely, since phenotypic
complementation by TNF occurs similarly with three in-
dependent transgenic lines carrying either correctly regu-
lated or overexpressing TNF transgenes (i.e., Tg1278 mice
[15] expressing correctly regulated levels of human wild-
type TNF, TgA86 mice [16] overexpressing a bioactive mu-
rine transmembrane TNF, or Tg6079 mice [our unpub-
lished data and not shown here] expressing wild-type murine
TNF). In addition, transgenic expression of LTa in LTa
knockout mice was reported recently as not sufficient to
rescue defective splenic architecture, although it could re-
store lymph node organogenesis (27). Interestingly, the ob-
served splenic phenotype of TgLTa/LTa2/2 mice seems
to be similar to the phenotype of TNF-deficient mice (6),
with B cells organized in ring-like structures around the
periarteriolar lymphoid sheath, and PNA1 patches forming
around central arterioles (see Fig. 4 C in reference 27).
Most importantly, decreased expression of the endoge-
nous TNF gene in LTa knockout mice could be docu-
mented in this study by TNF-specific quantitative assays
(Fig. 4). It is not clear, however, whether this defect in
TNF expression occurs at the level of gene transcription,
mRNA translation, or protein processing. Although this
certainly awaits further detailed characterization, it is tempt-
ing to speculate that defective expression of the TNF gene
in the LTa knockout mouse strain is due to transcriptional
interference caused by retention of a phosphoglycarate kinase
(PGK)-neo selection cassette within the targeted LTa locus.
This is now well documented in several other cases where re-
tention of the PGK-neo cassette in targeted loci has yielded
unexpected phenotypes due to the altered expression of
neighboring genes (28, 29). In light of the evidence presented
here, interpretation of the different phenotypes occurring in
the LTa knockout mice should be carefully readdressed.
Interestingly, although expression of TNF is sufficient,
even in the absence of LTa, to drive white pulp organiza-
tion into distinct B and T cell areas and to partially support
follicular structure and germinal center formation, the func-
tion of LTs is clearly required for the development of the
marginal zone, as documented in this study but also as sug-
gested previously by the complete absence of marginal
zone structures in LTb-deficient mice (11, 12). In this con-
text, it is perhaps not very surprising that humoral re-
sponses to SRBC, as measured in the TNF-complemented
LTa knockout system, although partially restored could
Figure 2. Restoration of FDC networks and germinal centers but not marginal zones in TgTNF/LTa2/2 mice. Immunocytochemical analysis was
performed on cryostat sections of spleens from LTa2/2, LTb2/2, 1278/LTa2/2, A86/LTa2/2, and wild-type control mice. For the detection of FDC
networks and germinal centers, spleens were harvested from mice 10 d after immunization with 108 SRBC. Blue, CR1, PNA, and ER-TR9 stainings;
brown, B220; red, sialoadhesin (Siaload.). Original magnifications: 3285 for CR1/B220 staining, 3155 for PNA/B220 staining, and 3100 for ER-TR9/
sialoadhesin staining.
Figure 3. Immune response to the TD antigen SRBC. Wild-type
(WT), LTa2/2, and 1278/LTa2/2 mice were immunized intraperito-
neally with 108 SRBC in PBS on days 0 and 21. Mice were bled on day
28, at which time serum titers to SRBC-specific IgG1 were determined
by ELISA. Data are means 6 SE of five mice per group.
Figure 4. ELISA analysis of TNF levels after LPS induction. LTa2/2
(n 5 5) mice and wild-type (WT; n 5 4) controls were injected intraperi-
toneally with 100 mg LPS, and serum levels of TNF were determined 90
min later. Thioglycollate-elicited peritoneal macrophages from LTa2/2
(n 5 4) mice and wild-type (n 5 3) controls were stimulated with 1 mg/ml
LPS for 24 h, and supernatants from individual cultures were assayed for
the presence of TNF. Data are means 6 SE per group. *P ,0.03; 11P
,0.001 compared with wild-type mice.752 Role of TNF/LT in Splenic Architecture
not reach normal levels. This may be due to the presence
of a suboptimal number of germinal centers in the spleen of
these mice, but it may also be due to the documented com-
plete absence of marginal zones in this system. Indeed,
marginal zones are thought to play an important role in
processing particulate antigens such as SRBC (30).
Taken together with the presence of mesenteric and cer-
vical lymph nodes in LTb-deficient mice (11, 12), our evi-
dence that TNF-complemented LTa knockout mice still
lack their mesenteric and peripheral lymphoid organs sup-
ports previous suggestions that LTa should have additional
lymphoid organogenetic functions, independent of LTb
(11). It is perhaps interesting to note that correct B/T cell
segregation, and also primary follicular organization and
germinal center reactivity, appear in this study to be tightly
regulated phenomena occurring in the absence of preserved
marginal zone structures, and seemingly uninfluenced by a
coinciding complete absence of secondary lymphoid or-
gans. Therefore, it seems that they represent primary phe-
nomena directly dependent on the local functioning of
TNF and LTs.
Inhibition of LTab signaling either in transgenic mice
expressing a soluble LTbR–IgG1 fusion protein (31), or by
administration of soluble LTbR–Ig fusion proteins in nor-
mal adult mice (32), was shown to have profound effects
on splenic organization. Similar effects were not observed
when a p55TNFR–Ig fusion protein was administered to
adult mice, suggesting that at least within the 3–4-wk time
frame of inhibition, the TNF/p55TNFR system is not re-
quired for the maintenance of splenic architecture (32). We
and others have previously suggested that a function for
TNF/p55TNFR in splenic organization may be in the de-
velopment and differentiation of FDC networks which
would then support follicular organization and germinal
center reactivity. If this is true, then given the long-living
character of the FDCs, one would expect that only long-
term inhibition of TNF signaling would be revealing for a
role in the maintenance of splenic organization in the adult.
The role of the TNF/p55TNFR system may also seem dis-
pensable for correct B/T cell segregation, since this phe-
nomenon is not affected in either TNF (6) or p55TNFR
knockout mice (14). However, our present evidence sug-
gests that even in the absence of LTs, TNF is sufficient to
suboptimally support development and maintenance of fol-
licular organization, indicating that the LT system shares a
redundant role with TNF in regulating the conserved ap-
pearance of splenic white pulp areas. In addition to the
splenic defects, administration of LTbR–Ig during gesta-
tion disrupted lymph node development (33), suggesting a
basic organogenetic role for LTa/b in these processes.
However, a differential role for TNF/p55TNFR in these
phenomena is suggested by the presence of secondary lym-
phoid organs with clear B/T cell zone segregation in the
TNF- (6) or p55TNFR-deficient strains of mice (14). As
discussed above, a function for TNF/p55TNFR in splenic
organization may be in the development and differentiation
of FDC networks which would then support follicular orga-
nization and germinal center reactivity (6, 7, 34). In support
of this hypothesis, recent bone marrow transplantation ex-
periments in LTa- and p55TNFR-deficient mice showed
that FDC clustering induced by wild-type bone marrow
transfers is dependent on the presence of the p55TNFR on
nonhematopoietic cells (35, 36). On the other hand, the
LT/LTbR system is expected to function on hematopoie-
tic lineage cell interactions with nonlymphocytic stroma el-
ements (37, 38), and it may be that such interactions con-
trol the basic architecture, which appears essential for the
organogenesis of the lymph nodes but also for the fine
structural organization of the spleen. Formation of FDC
networks should be a composite phenomenon requiring an
optimal splenic infrastructure, perhaps provided by LTs,
and a TNF/p55TNFR-specific signal which leads to the
maturation/differentiation and/or follicular localization of
FDCs. The capacity to form FDC networks and germinal
centers even in the absence of LTs, as documented in both
TNF-complemented LTa knockout mice and LTb
knockout mice, supports this hypothesis. Therefore, it is
likely that the role of LTs is functionally distinct from that
of TNF, and that both pathways need to cooperate for the
optimal development and maintenance of splenic structure.
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